🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

445 results for “SK” Clear

  1. Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (risankizumab biosimilar), with EU-approved Skyrizi®, and US licensed Skyrizi® in Healthy Adult Participants

    Lacuna Pharma Pty Ltd

    Active psoriatic arthritis, Moderately to severely active Crohn’s disease, Moderate-to-severe plaque psoriasis, Moderately to severely active ulcerative colitis

    phase 1 other active

    1 trial

  2. Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)

    Lacuna Pharma Pty Ltd

    Immune-mediated necrotizing myopathy, Antiphospholipid syndrome, Behçet’s Syndrome, Bullous pemphigoid, Dermatomyositis, Immune Thrombocytopenia

    phase 1 other active

    1 trial

  3. Phase Ib Open Label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial)

    Lacuna Pharma Pty Ltd

    Bullous pemphigoid, Behçet’s Syndrome, Dermatomyositis, Antiphospholipid syndrome, Immune-mediated necrotizing myopathy, Immune Thrombocytopenia

    phase 1 other active

    1 trial

  4. R-enantiomer of 1,2-dioleoyl-3-trimethylammonium-propane chloride + Peptides from HPV-16 E6 and E7

    PDS Biotechnology Corp

    High-risk HPV Infection and Biopsy-proven CIN1

    phase 1 mab completed

    1 trial

  5. Repomol, Metronidazol ”Baxter” Viaflo, infusionsvæske, opløsning, Saline Solution Basi 9 mg/ml solution for infusion, Fosfomycin "Infectopharm", pulver til infusionsvæske, opløsning 40 mg/ml

    Lacuna Pharma Pty Ltd

    peritonitis

    phase 1 small molecule active

    1 trial

  6. SKY0402

    Pacira Ireland Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  7. SKY0402

    Pacira Ireland Limited

    Postoperative Pain Management

    phase 1 small molecule completed

    1 trial

  8. SKY0402 300mg in healthy patients

    Pacira Ireland Limited

    Pain

    phase 1 small molecule completed

    1 trial

  9. SPECT/CT imaging of FPI-2505 in patients with solid tumours; a phase 0 molecular imaging basket trial (SCOPE-study).

    Lacuna Pharma Pty Ltd

    small cell lung cancer, non-smallcell lung cancer, colorectal cancer, breast cancer, Pancreatic cancer and gastric cancer

    phase 1 other active

    1 trial

  10. Safety of TEG001 in patients with r/r AML/high-risk MDS or r/r MM

    Disc Medicine

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma (MM)

    phase 1 other active

    1 trial

  11. Study of diclofenac skin reservoir formation and emptying after Voltaren Emulgel 2.32% application in healthy participants

    HALEON AUSTRALIA PTY LTD

    For the local, symptomatic treatment of pain in acute bruises, strains, or sprains due to blunt trauma, e.g., sports and accident injuries

    phase 1 other active

    1 trial

  12. Takeda Brentuximab; Molecular Imaging of Zirconium-89-labeled Brentuximab as a Tool to Investigate brentuximab biodistribution in CD30-positive Lymphoma

    Disc Medicine

    Patients with stage II-IV high risk diffuse large B-cell lymphoma, defined as international prognostic index > 2, Lymphoma

    phase 1 other active

    1 trial

  13. To evaluate the pharmacokinetics and safety of nolasiban

    Novo Nordisk A/S

    not applicable (submitted trial is a pharmacokinetic study in healthy subjects)

    phase 1 other active

    1 trial

  14. WSK-IM05 (4×10^10 vp)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HPV-positive Oropharyngeal Squamous Cell Carcinoma

    phase 1 mab active

    1 trial

  15. [14C]-GSK961081 solution for IV infusion

    Theravance Biopharma Ireland Umited

    Pulmonary Disease, Chronic Obstructive

    phase 1 small molecule completed

    1 trial

  16. [14C]HSK7653

    The First People's Hospital of Lianyungang

    Type II Diabetes

    phase 1 small molecule completed

    1 trial

  17. [203Pb]VMT01

    Perspective Therapeutics

    Melanoma (Skin)

    phase 1 small molecule completed

    1 trial

  18. evorpacept

    ALX ONCOLOGY HOLDINGS INC

    Higher Risk Myelodysplastic Syndromes

    phase 1 small molecule terminated

    1 trial

  19. rHuPH20

    HALOZYME THERAPEUTICS, INC.

    Risk Factors for or a Diagnosis of Osteoporosis

    phase 1 small molecule completed

    1 trial

  20. ALUTARD SQ epitel, injektionsvätska, suspension - 553 Hund, Livostin 0,5 mg/ml ögondroppar, suspension, Desloratadine Sandoz 5 mg filmdragerade tabletter, Nasonex 50 mikrogram/dos nässpray, suspension

    The George Institute

    Allergic rhinitis due to dog allergy

    approved small molecule active

    1 trial

  21. ASS-ratiopharm® 100 mg TAH Tabletten, Xarelto 15 mg film-coated tablets

    The George Institute

    Risk of stroke by Atrial Fibrillation

    approved small molecule active

    1 trial

  22. Advair Diskus100/50 µg

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  23. Aliskiren

    Novartis Pharmaceuticals

    Hypertension

    approved small molecule completed

    1 trial

  24. Aliskiren

    United Therapeutics Europe Ltd

    IgA Nephropathy

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources